SURI
SURI
About Simplify Propel Opportunities ETF
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation. The fund is sub-advised by Propel, which uses its deep scientific and commercial...
About Simplify Propel Opportunities ETF
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation. The fund is sub-advised by Propel, which uses its deep scientific and commercial...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 PAGP | Plains GP Holdings, L.P. | 36.76% | 1.27M | $28.68M |
 ACHV | Achieve Life Sciences, Inc. | 6.92% | 1.18M | $5.40M |
 PHAT | Phathom Pharmaceuticals, Inc. | 4.93% | 306.33K | $3.85M |
 MIST | Milestone Pharmaceuticals Inc. | 3.30% | 1.51M | $2.58M |
 ABEO | Abeona Therapeutics Inc. | 3.28% | 500.34K | $2.56M |
 CLDX | Celldex Therapeutics, Inc. | 3.28% | 85.00K | $2.56M |
 DCTH | Delcath Systems, Inc. | 2.98% | 261.13K | $2.32M |
 OCS | Oculis Holding AG | 2.79% | 74.07K | $2.18M |
 VRDN | Viridian Therapeutics, Inc. | 2.75% | 73.01K | $2.15M |
 IVA | Inventiva S.A. | 2.11% | 253.25K | $1.64M |
 KYTX | Kyverna Therapeutics, Inc. | 2.02% | 192.34K | $1.58M |
 CORT | Corcept Therapeutics Incorporated | 1.73% | 37.76K | $1.35M |
 LENZ | LENZ Therapeutics, Inc. | 1.59% | 91.79K | $1.24M |
 FDMT | 4D Molecular Therapeutics, Inc. | 1.42% | 114.79K | $1.11M |
 CMPS | COMPASS Pathways plc | 1.41% | 159.05K | $1.10M |
 ZVRA | Zevra Therapeutics, Inc. | 1.36% | 118.82K | $1.06M |
 KLRS | Kalaris Therapeutics Inc | 1.17% | 87.43K | $914.48K |
 TRVI | Trevi Therapeutics, Inc. | 1.11% | 72.68K | $866.33K |
 SABS | SAB Biotherapeutics, Inc. | 1.09% | 208.23K | $853.73K |
 LONA | LeonaBio, Inc. | 1.08% | 149.28K | $840.44K |
SECTOR HOLDINGS
Healthcare
EnergyASSET ALLOCATION BY REGION
United States
Canada
Switzerland
France
United Kingdom
Cayman IslandsSECTOR HOLDINGS
Healthcare EnergyASSET ALLOCATION BY REGION
United States Canada Switzerland France United Kingdom Cayman IslandsHoldings (Top 20)
PAGP
Plains GP Holdings, L.P.
ACHV
Achieve Life Sciences, Inc.
PHAT
Phathom Pharmaceuticals, Inc.
MIST
Milestone Pharmaceuticals Inc.
ABEO
Abeona Therapeutics Inc.
CLDX
Celldex Therapeutics, Inc.
DCTH
Delcath Systems, Inc.
OCS
Oculis Holding AG
VRDN
Viridian Therapeutics, Inc.
IVA
Inventiva S.A.
KYTX
Kyverna Therapeutics, Inc.
CORT
Corcept Therapeutics Incorporated
LENZ
LENZ Therapeutics, Inc.
FDMT
4D Molecular Therapeutics, Inc.
CMPS
COMPASS Pathways plc
ZVRA
Zevra Therapeutics, Inc.
KLRS
Kalaris Therapeutics Inc
TRVI
Trevi Therapeutics, Inc.
SABS
SAB Biotherapeutics, Inc.
LONA
LeonaBio, Inc.